This article is published in association with European Investment Bank. The European Investment Bank (EIB) is providing venture debt financing to Belgian medical-technology company Nyxoah €37.5 million to develop treatments against obstructive sleep apnea. This transaction aligns with the EIB’s priority objective to boost research and technological innovation, in line with the implementation of EU policies. […]Belgian medtech Nyxoah secures €37.5 million EIB venture-debt financing to treat obstructive sleep apnea
July 4, 2024 by Leave a Comment
This article is published in association with European Investment Bank. The European Investment Bank (EIB) is providing venture debt financing to Belgian medical-technology company Nyxoah €37.5 million to develop treatments against obstructive sleep apnea. This transaction aligns with the EIB’s priority objective to boost research and technological innovation, in line with the implementation of EU policies. […]
